Steven Cohen Applied Genetic Technologies Corp Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$2.62 - $4.44 $442,001 - $749,041	-168,703 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.85 - $7.35 $174,393 - $332,932	-45,297 Reduced 21.17%	168,703 $1.23 Million
Q2 2018 Aug 14, 2018	BUY	$3.7 - $5.65 $125,800 - $192,100	34,000 Added 18.89%	214,000 $792,000
Q1 2018 May 15, 2018	BUY	$3.65 - $5.2 $657,000 - $936,000	180,000 New	180,000 $693,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.